Case Study: Fast-Tracking Enrollment for a Global Phase 3 Norovirus Vaccine Trial

Fast-Tracking Enrollment for a Global Phase 3 Norovirus Vaccine Trial

Tekton Research achieved an average of one day from site activation to first patient visit across seven sites in a Phase 3 norovirus vaccine trial.